Abstract:Multiresponsive nanoprobes are highly desirable for low background and highly sensitive imaging in biomedical applications. Herein, we design a glutathione (GSH)/pH dual-responsive nanoprobe capable of both fluorescence imaging in cells and 19F magnetic resonance imaging (19F MRI) in deep tissue, by encapsulating manganese oleate (Mn(OA)2) on the surface of fluorinated fluorescent quantum dots (F-ZnS:Mn2+). In this approach, Mn(OA)2 serves as an efficient quencher of both fluorescence and 19F MRI signal. Both the fluorescence and 19F MRI signal can be turned on by introducing glutathione (GSH) that breaks up the Mn–O bonds within Mn(OA)2 under weak acidity conditions (e.g., pH 6.0). The imaging results in cells and mice suggest that this novel strategy can offer a promising nanoprobe for turn-on fluorescence/19F MRI dual-modal tumor imaging.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c01786?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c01786</a>.XRD pattern of ZnS:Mn2+ QDs (Figure S1); HRTEM images of ZnS:Mn2+-F-Mn(OA)2@PSIOAm before and after reaction with GSH (Figure S2); FT-IR spectra of ZnS:Mn2+ QDs (the ligand is oleic acid), Mn(OA)2, PFCE, PSIOAm, and ZnS:Mn2+-F-Mn(OA)2@PSIOAm (Figure S3); UV–Vis absorption spectrum of Mn(OA)2 and fluorescence spectra of ZnS:Mn2+@PSIOAm and ZnS:Mn2+-Mn(OA)2@PSIOAm (Figure S4); UV–Vis absorption of ZnS:Mn2+OAm and ZnS:Mn2+-F-Mn(OA)2@PSIOAm (Figure S5); 19F NMR spectra of ZnS:Mn2+-F-Mn(OA)2@PSIOAm aqueous solution before and after reaction with GSH (10 mM) at pH 6.0 (Figure S6); UV–Vis absorption spectra and ICP-OES measurements of the Mn content in the supernatants of ZnS-Mn(OA)2@PSIOAm colloidal solution under different conditions (Figure S7); selectivity of ZnS:Mn2+-F-Mn(OA)2@PSIOAm toward GSH (Figure S8); cytotoxicity tests of ZnS:Mn2+-F-Mn(OA)2@PSIOAm colloids after incubation with HUVECs and 4T1 cell lines (Figure S9); flow cytometry analysis of MREpiC and 4T1 cells incubated with ZnS:Mn2+-F-NLR-Mn(OA)2@PSIOAm (Figure S10); stability evaluation of ZnS:Mn2+-F-Mn(OA)2@PSIOAm colloid solution (Figure S11); T1-weighted and T2-weighted 1H MR imaging of ZnS:Mn2+-F-Mn(OA)2@PSIOAm under different conditions (Figure S12); and fluorescence images of 4T1 cells cultured with ZnS:Mn2+-F-Mn(OA)2@PSIOAm nanoprobes for different time (Figure S13) (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c01786/suppl_file/ac0c01786_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Integrating Fluorinated Polymer and Manganese-Layered Double Hydroxide Nanoparticles as pH-activated 19 F MRI Agents for Specific and Sensitive Detection of Breast Cancer.

Targeting Pancreatic Cancer Cells with Peptide-Functionalized Polymeric Magnetic Nanoparticles

Ultra-Small and Metabolizable Near-Infrared Au/Gd Nanoclusters for Targeted FL/MRI Imaging and Cancer Theranostics

High F-Content Perfluoropolyether-Based Nanoparticles for Targeted Detection of Breast Cancer by 19F Magnetic Resonance and Optical Imaging

Manganese-based magnetic layered double hydroxide nanoparticle: a pH-sensitive and concurrently enhanced T1/T2-weighted dual-mode magnetic resonance imaging contrast agent for accurate cancer diagnosis

Fluoropolymer-MOF Hybrids with Switchable Hydrophilicity for 19F MRI-Monitored Cancer Therapy.

Hollow Manganese Phosphate Nanoparticles As Smart Multifunctional Probes for Cancer Cell Targeted Magnetic Resonance Imaging and Drug Delivery

Ligand‐Mediated Magnetism‐Conversion Nanoprobes for Activatable Ultra‐High Field Magnetic Resonance Imaging

Folate Receptor Targeting Mn(II) Complex Encapsulated Porous Silica Nanoparticle as an MRI Contrast Agent for Early‐State Detection of Cancer

Polydopamine Coated Manganese Oxide Nanoparticles with Ultrahigh Relaxivity As Nanotheranostic Agents for Magnetic Resonance Imaging Guided Synergetic Chemo-/Photothermal Therapy.

pH‐responsive albumin‐mimetic synthetic nanoprobes for magnetic resonance/fluorescence imaging of thyroid cancer

Manganese Oxide/metal-Organic Frameworks-Based Nanocomposites for Tumr Micro-environment Sensitive 1H/19F Dual-mode Magnetic Resonance Imaging in Vivo

Furin‐Controlled Fe3O4 Nanoparticle Aggregation and 19F Signal “Turn‐On” for Precise MR Imaging of Tumors

Manganese Oxide-Based Multifunctionalized Mesoporous Silica Nanoparticles for Ph-Responsive Mri, Ultrasonography and Circumvention of Mdr in Cancer Cells

Novel Nanoprobe with Combined Ultrasonography/Chemical Exchange Saturation Transfer Magnetic Resonance Imaging for Precise Diagnosis of Tumors

In Vivo Targeted Magnetic Resonance Imaging and Visualized Photodynamic Therapy in Deep-Tissue Cancers Using Folic Acid-Functionalized Superparamagnetic-Upconversion Nanocomposites

99mTc-conjugated manganese-based mesoporous silica nanoparticles for SPECT, pH-responsive MRI and anti-cancer drug delivery.

Hydrogen-Bonded Organic Frameworks Chelated Manganese for Precise Magnetic Resonance Imaging Diagnosis of Cancers

Targeted Fluorescent Magnetic Nanoparticles for Imaging of Human Breast Cancer.

Multiresponsive Nanoprobes for Turn-On Fluorescence/ 19 F MRI Dual-Modal Imaging

Surface modification of Gd nanoparticles with pH-responsive block copolymers for use as smart MRI contrast agents.